Atlas Trials

[18F]-Fludarabine PET/MRI in Primary Central Nervous System Lymphoma

Clinical trial NCT05390814 · COMPLETED

Trial details

NCT number
NCT05390814
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Primary Central Nervous System Lymphoma
Start date
2023-12-18
Primary completion
2024-12-05
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.